Magnetic pulses to the brain may limit stroke damage, early trial hints

NCT ID NCT06064734

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This pilot study tested whether low-frequency magnetic stimulation (rTMS) applied to the brain within 48 hours of an acute ischemic stroke could reduce the growth of damaged tissue and lower disability. Sixty adults aged 18–80 with moderate to severe strokes were enrolled. The treatment involved two daily sessions over three days. The goal was to see if this safe, non-invasive approach could improve outcomes without the need for clot-busting drugs or surgery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Low-frequency repetitive transcranial magnetic stimulation (rTMS) device
What this could lead to
If it works, this could point toward a non-drug treatment to limit stroke damage and improve recovery when given soon after a stroke.
What could go wrong
This is a small, early pilot trial with only 60 people, so results may not apply widely. The treatment is also experimental and may not reduce disability or could cause side effects like bleeding.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for STROKE, ACUTE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Beijing Tian tan Hospital

    Beijing, Beijing Municipality, 100070, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.